Bruno Brasileiro, Calcium

Calcium+Company, a leading mid-sized diversified health communications group, is pleased to announce the promotion of Bruno Brasileiro from Executive Creative Director to Chief Creative Officer, based in the New York office.

GSK

The agency approved a label expansion for GSK’s respiratory syncytial virus vaccine Arexvy, allowing its use in adults aged 50 through 59 years who have a medical condition that increases their risk of severe outcomes.

Pfizer

The results, published Friday in JAMA Internal Medicine, showed that at 10 weeks, Paxlovid did not significantly lower the severity of the six core symptoms of long COVID, compared with patients who were treated with placebo and ritonavir.

Abbott

The company announced that the FDA cleared its two continuous glucose monitoring systems for over-the-counter use.

Moderna

In the study, the combination using messenger RNA technology generated greater antibodies than currently marketed traditional flu vaccines and Moderna’s Spikevax mRNA COVID shot, the company said.

Evidence that weight-loss drugs like Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound can cut heart disease risk, treat sleep apnea and address other health issues may help convince more men to use them, five doctors who prescribe the medicines regularly told Reuters.